Viking Therapeutics announced on Wednesday that it will accelerate the development of its investigational subcutaneous GLP-1/GIP receptor dual agonist VK2735 for obesity, with an eye towards starting Phase III development in the coming months
Exendin-4 induces bone marrow stromal cells migration through bone marrow-derived macrophages polarization via PKA-STAT3 signaling pathway
Potential roles of redox dysregulation in the development of schizophrenia
Talk to our team Two convenient centers close to home We serve clients from Rockville, Takoma Park, MD, Silver Spring, Germantown, Potomac, Frederick, Clarksburg and surrounding areas in Maryland, Northern Virginia and Washington, DC.
The signaling of molecules that operate primarily in the brain is disturbed by microbial factors, obesity and diabetes
Crepey skin is always caused by a lack of collagen support